Business Context and Reporting Period
Company: Marchex, Inc. (MCHX)
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2026
Event: Entry into a Material Definitive Agreement (Stock Purchase Agreement) to acquire 100% of Archenia, Inc.
Key Financial Metrics and Transaction Terms
This filing details a proposed acquisition rather than reporting standard periodic financial results (revenue, profit, cash flow). Key transaction financials include:
- Base Consideration: $10 million in convertible promissory notes issued to sellers.
- Note Terms: 6% interest, payable in three equal tranches at 12, 18, and 24 months post-closing.
- Conversion Rate: Notes convertible into Marchex Class B common stock at $1.80 per share.
- Earn-out Consideration: Up to 2 million shares of Class B common stock for each of the first two 12-month periods post-closing, contingent on Archenia exceeding prior revenue/Adjusted EBITDA and meeting integration/retention targets.
- Liquidity/Debt Impact: The filing does not provide current liquidity or debt figures; the transaction introduces new debt obligations subject to conversion.
Material Changes and Transaction Structure
The primary material change is the agreement to acquire Archenia, Inc. The transaction involves related parties, necessitating approval by a Special Committee of independent directors and a majority of disinterested stockholders. A fairness opinion was provided by Craig-Hallum Capital Group LLC. The transaction is expected to close in early Q3 2026, subject to closing conditions.
Guidance, Risks, and Contingencies
- Contingencies: Closing is subject to stockholder approval and satisfaction of customary conditions. Earn-out shares are contingent on future performance metrics of Archenia.
- Related Party Transaction: Certain sellers are related parties, requiring independent review and stockholder ratification.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks such as product demand, competition, and general economic conditions that could cause actual results to differ from expectations.
- Management Commentary: No specific financial guidance for Marchex's standalone operations is provided in this filing.
Investor Verification Checklist
- Verify the final terms of the Stock Purchase Agreement (SPA) in the upcoming proxy statement.
- Confirm the outcome of the required stockholder vote for the related-party transaction.
- Review the fairness opinion from Craig-Hallum Capital Group LLC regarding the $1.80 conversion price and earn-out structure.
- Monitor the proxy statement for details on the specific integration and customer retention targets required to trigger the earn-out shares.
- Check for any updates on the expected Q3 2026 closing date.